Last reviewed · How we verify
NCT03195504
High-flow Nasal Oxygenation in Obese Patients During Apnea
NA trial testing HFNC in Apneic Oxygenation in 40 participants. Completed in 1 April 2018.
1 April 2018
Quick facts
| Lead sponsor | University Health Network, Toronto |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 10 August 2017 |
| Primary completion | 1 April 2018 |
| Estimated completion | 1 April 2018 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- HFNC
- CON (control)
Conditions studied
- Apneic Oxygenation — all drugs for Apneic Oxygenation →
- High-flow Nasal Cannulae — all drugs for High-flow Nasal Cannulae →
- Bariatric Surgery — all drugs for Bariatric Surgery →
- Anesthesia Induction — all drugs for Anesthesia Induction →
Sponsor
University Health Network, Toronto
Who can join
18 and older, any sex, with Apneic Oxygenation or High-flow Nasal Cannulae. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Before going off to sleep patients are given oxygen to saturate blood with oxygen to extend time before a decrease in the level of oxygen in the blood occurs. During this period, obese patients have a faster decrease in the level of oxygen in their blood. This study uses a device called "high-flow nasal cannula" (HFNC), which delivers humidified high-flow oxygen through 2 small plastic tubes placed just inside nostrils. In the intensive care unit settings this device has been used extensively and has become a standard practice. Purpose of this study is to determine whether these high-flow nasal cannula increase the time safely when going to sleep during elective surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03195504
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of HFNC
Trials testing the same drug.
- NCT05962073 — Comparison Physiological Effects According to Preoxygenation Method Using EIT · NA · withdrawn
- NCT04693403 — The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) Study · NA · completed
- NCT05425836 — HFNC Versus SOT During EBUS · NA · completed
- NCT05548309 — HFNC Versus Oxygen Face Mask on Postoperative Pulmonery Complications · NA · completed
- NCT05708287 — The Physiologic Effect of the Flow Generated by High Flow Nasal Cannula in Mild Respiratory Failure · NA · completed
Other University Health Network, Toronto trials
Trials by the same sponsor.
- NCT06831032 — Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response · NA · recruiting
- NCT06634056 — Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients U · Phase 2 · not yet recruiting
- NCT06836726 — Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resis · Phase 2 · not yet recruiting
- NCT07515651 — Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas · Phase 2 · not yet recruiting
- NCT07509450 — Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cel · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03195504 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Health Network, Toronto
- Last refreshed: 19 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03195504.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing